Medical Devices Investors & VC Firms in Asia-Pacific

178 firms in this list, with a median first check of $1M. 28 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AG Agate Medical Investments LP	88🔒	Tel-Aviv	IL	Growth–Late Stage	—	+ Add to CRM
AD AddVentures by SCG SPCLPJRM6 people	88🔒	Bangkok	TH	Seed–Late Stage	$1.5M – $66M	+ Add to CRM
AR Archetype Ventures HKJNKMSF6 people	88🔒	Tokyo	JP	Pre-Seed–Growth	$875K – $92M	+ Add to CRM
BI Birch Venture Capital, Inc. MWLLMT5 people	88🔒	Taipei City	TW	Seed–Late Stage	—	+ Add to CRM
NO Nordic Capital KMCHHJJS7 people · Leads rounds	88🔒	Copenhagen	DK	Growth–Late Stage	—	+ Add to CRM
SM Smilegate Investment BAHCHNIP11 people	88🔒	Seoul	KR	Seed–Growth	$694K – $35M	+ Add to CRM
SO Southern Cross Venture Partners BCJWDMJS5 people	88🔒	Narrabeen	AU	Seed–Late Stage	$1.3M – $6.6M	+ Add to CRM
TR TransPacific Venture Partners MLPJ2 people	88🔒	Taipei City	TW	Seed–Series B	$500K – $3M	+ Add to CRM
WH Whiz Partners Inc. 安俊藤朋HFTS6 people	88🔒	Tokyo	JP	Seed–Late Stage	$500K – $5M	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
SB SBCVC CSKCMZAS6 people	88🔒	Tortola	CN	Seed–Late Stage	—	+ Add to CRM
TE Tern ASBLIRIR6 people	88🔒	London	GB	Seed	—	+ Add to CRM
HB HBM Partners DDDUFDFD5 people	88🔒	Zug	CH	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
NE NewMargin Ventures YHCTHHHK5 people	88🔒	Shanghai	CN	Pre-Seed–Late Stage	$425K – $200M	+ Add to CRM
AS Asia Business Builders PSDLNTPQ6 people · Follows rounds	88🔒	—	VN	Growth	—	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL7 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM
DC DCI Partners Co. Ltd. HYWFHNLL4 people	88🔒	Tokyo	JP	Pre-Seed–Growth	$4.3M – $71M	+ Add to CRM
RA Raisewell Ventures JKCTJWKS7 people	88🔒	San Francisco Bay Area	US	Pre-Seed–Series B	—	+ Add to CRM
ST Sturgeon Capital RBSHKZSC4 people	88🔒	London	GB	Pre-Seed–Growth	$150K – $17M	+ Add to CRM
H. H.I.G. BioHealth Partners SMTTBSDB6 people	88🔒	—		Growth–Late Stage	—	+ Add to CRM
BL Black Marble Capital Management RCJHACFC12 people	88🔒	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
DI Diamond Biofund PYKLTLYC6 people	88🔒	Taipei	TW	Seed–Series B	—	+ Add to CRM
EV Even Capital	88🔒	—	NZ	Seed–Growth	—	+ Add to CRM
IS iSpring Capital Sdn. Bhd. ASSSDF3 people	88🔒	Petaling Jaya	MY	Pre-Seed–Series B	$150K – $1M	+ Add to CRM

Agate Medical Investments LP

Tel-AvivGrowth–Late Stage

AddVentures by SCG

BangkokSeed–Late Stage$1.5M – $66M

SPCLPJRM6 people

Archetype Ventures

TokyoPre-Seed–Growth$875K – $92M

HKJNKMSF6 people

Birch Venture Capital, Inc.

Taipei CitySeed–Late Stage

MWLLMT5 people

Nordic Capital

CopenhagenGrowth–Late Stage

KMCHHJJS7 people

Smilegate Investment

SeoulSeed–Growth$694K – $35M

BAHCHNIP11 people

Southern Cross Venture Partners

NarrabeenSeed–Late Stage$1.3M – $6.6M

BCJWDMJS5 people

TransPacific Venture Partners

Taipei CitySeed–Series B$500K – $3M

MLPJ2 people

Whiz Partners Inc.

TokyoSeed–Late Stage$500K – $5M

安俊藤朋HFTS6 people

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

SBCVC

TortolaSeed–Late Stage

CSKCMZAS6 people

Tern

LondonSeed

ASBLIRIR6 people

HBM Partners

ZugPre-Seed–Late Stage$5M – $50M

DDDUFDFD5 people

NewMargin Ventures

ShanghaiPre-Seed–Late Stage$425K – $200M

YHCTHHHK5 people

Asia Business Builders

Growth

PSDLNTPQ6 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL7 people

DCI Partners Co. Ltd.

TokyoPre-Seed–Growth$4.3M – $71M

HYWFHNLL4 people

Raisewell Ventures

San Francisco Bay AreaPre-Seed–Series B

JKCTJWKS7 people

Sturgeon Capital

LondonPre-Seed–Growth$150K – $17M

RBSHKZSC4 people

H.I.G. BioHealth Partners

Growth–Late Stage

SMTTBSDB6 people

Black Marble Capital Management

TaipeiSeed–Late Stage

RCJHACFC12 people

Diamond Biofund

TaipeiSeed–Series B

PYKLTLYC6 people

Even Capital

Seed–Growth

iSpring Capital Sdn. Bhd.

Petaling JayaPre-Seed–Series B$150K – $1M

ASSSDF3 people

Data sourced from public filings and firms' own websites — see our methodology.